Therapeutic Window
Therapeutic Window - Related Videos
03:15
Calvarial Window Generation in Mouse Model: A Surgical Procedure to Create Window in the Top Part of the Mouse Skull
0 Views •
2023
In this video, we describe the surgical procedure to create a calvarial window for accessing the brain of a mouse model.
15:01
Windowing Chicken Eggs for Developmental Studies
0 Views •
Cited by 37 •
2007
The ease of accessibility of the embryo has allowed for experiments to map cell fates using several approaches, including chick quail chimeras and focal dye labeling. In this article we demonstrate one egg preparation method that has been optimized for long survival times.
09:12
Dendra2 Photoswitching through the Mammary Imaging Window
0 Views •
Cited by 63 •
2009
Intravital photoswitching and tracking of Dendra2-labeled tumor cells through the Mammary Imaging Window is a technique which allows us to image the metastatic behavior of tumor cells in chosen tumor microenvironments over a timescale of days.
11:17
Extinction Training During the Reconsolidation Window Prevents Recovery of Fear
0 Views •
Cited by 50 •
2012
Conditioned fear can be diminished through an inhibitory process called extinction, but can resurface under conditions such as the passage of time or exposure to stress. Our protocol presents a novel way of preventing fear recovery by introducing extinction during the reconsolidation window (the re-storage phase of a reactivated memory).
01:13
Therapeutic Index
0 Views •
2025
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
FAQs
Drug exposure alone does not determine whether treatment succeeds; pharmacodynamic response connects concentration with both benefit and harm. A concentration may therefore be clinically useful only when it produces the intended effect without reaching levels where toxicity becomes likely. This concentration-response relationship explains why dose decisions require both efficacy and safety considerations.
Absorption, distribution, metabolism, and excretion shape the concentration-time profile after a dose. Changes in any of these pharmacokinetic processes can alter exposure, even when the prescribed dose stays the same. Clinicians account for this variability when evaluating whether a patient remains within the desired range or needs treatment adjustment.
A narrow therapeutic window leaves little separation between concentrations associated with benefit and those associated with toxicity. Consequently, relatively small exposure changes can have clinically important consequences. Such medicines call for especially careful monitoring, because loss of exposure may reduce efficacy while excess exposure may increase the likelihood of serious adverse effects.
Therapeutic drug monitoring uses measured drug concentrations to support clinical decisions about dosing. Clinicians interpret those measurements alongside the desired clinical effect and possible toxicity, rather than treating a concentration as an isolated result. This approach is particularly important when small changes in exposure could shift treatment from ineffective to harmful.
Patient-specific factors matter because they can change how a dose becomes drug exposure over time. By considering the patient’s pharmacokinetic circumstances and observed response, clinicians can select or modify a dose instead of assuming that one dose produces the same concentration in everyone. The goal is to preserve benefit while limiting toxicity.
In clinical practice, the therapeutic window helps organize three linked decisions: choosing an initial dose, recognizing whether treatment is producing the intended effect, and deciding when adjustment is needed. Its value is greatest when efficacy and toxicity must be balanced closely, allowing concentration information and clinical response to guide safer medication use.